F amilial combined hyperlipidemia (FCHL) is
characterized by variable expression of hypercholesterolemia and hypertriglyceridemia in a given family, with either or both present in affected individuals. 1 FCHL is associated with an excess risk of coronary artery disease (CAD) and was first reported by Goldstein et al 1 in 1973 in pedigrees ascertained through men who were survivors of myocardial infarction; over 10% of those probands were considered to have FCHL. One half to one third of familial premature CAD 2 and at least 10% of all premature CAD 1 -3 are ascribed to FCHL. This disorder is estimated to affect 1% to 2% of those in the populations studied and may be responsible for 5% of myocardial infarctions. 1 While the inheritance of FCHL was originally described as consistent with an autosomal dominant disorder with full penetrance by the end of the third decade, 1 formal segregation analysis, adjusting for ascertainment, has not been reported. 4 Thus, the mode of inheritance remains uncertain.
Efforts to refine the phenotype of FCHL have led to the observation that elevated levels of apolipoprotein (apo) B are commonly observed in individuals with FCHL. 5 An increased rate of hepatic secretion of apoB associated with very-low-density lipoprotein (VLDL) in subjects with FCHL has been documented by many groups. 610 Defective regulation of apoB metabolism may be responsible for the development of FCHL, and the elevated levels of apoB may contribute to the CAD associated with FCHL. Elevated apoB level is a strong predictor of CAD. 1115 Since FCHL is associated with elevated apoB levels, genetic factors that influence apoB levels may influence risk of FCHL. There is evidence of multiple loci controlling apoB levels. In several studies using complex segregation analysis to evaluate the sources of interindividual variability in apoB levels in samples of adults enriched for hyperlipidemic subjects, 40% or more of the variation in age-and sex-adjusted apoB levels has been ascribed to an unmapped codominant mendelian locus. 1620 Predicted genotype at this putative apoB level locus also predicts variation in low-density lipoprotein cholesterol (LDL-C) and trigryceride levels. 1618 - 20 The probable genotype at this locus was subsequently found to be predictive of FCHL as well. 2021 The predominance of small, dense LDL as determined by gradient gel electrophoresis, denoted LDL subclass phenotype B, has been associated with increased apoB levels. 24 ApoB levels also vary with polymorphisms at the apoA-I/C-III/A-IV gene cluster, 29 the apoE structural locus, 30 and possibly the apoB structural locus, 31 -32 although the apoB and apoE polymorphisms have not been specifically associated with FCHL. 33 If elevated apoB levels are involved in the etiology of FCHL, this may be one source of the etiologic heterogeneity in this disorder. Several sources of evidence for such heterogeneity exist. Only 52% of those with FCHL had evidence for the presence of the apoB-level locus allele that was associated with FCHL. A portion of those with FCHL appear to be heterozygous for lipoprotein lipase deficiency. 34 - 33 A defect in the action of serum basic proteins in free fatty acid metabolism may account for some cases of FCHL. 36 -37 Locus heterogeneity is suggested by the evidence for linkage of FCHL to the apoA-I/C-III/A-IV gene cluster on chromosome 11 in only a subset of families with FCHL 38 and not in other families with FCHL. 39 The ability to categorize genetically heterogeneous subsets of FCHL will aid in the determination of the etiologic defects and in the mapping of genes responsible for FCHL.
A better understanding of the relation of genotypic variation at the unmapped apoB-level locus and LDL subclass phenotype locus to each other and to FCHL may help to clarify whether they play a role in the pathophysiology of FCHL. Thus, the goals of the current study were (1) to investigate the mode of transmission of apoB levels in four large pedigrees ascertained through probands with hypertriglyceridemia that was ascribed to FCHL; (2) to test for evidence of heterogeneity in the mode of transmission; (3) to determine whether LDL subclass phenotype and apoB level major locus genotype represent distinct genetic traits or represent correlated measures of the same trait; and (4) to test whether LDL subclass phenotype B and putative apoB level genotype predict FCHL in these pedigrees.
Methods

Phenotype Determinations
The total apoB level of fasting subjects was measured by radioimmunoassay. 40 23 In addition, 13 individuals had indeterminate results and 11 did not have gels run due to plasma sample unavailability.
Families
Analyses were performed using a sample of four large pedigrees with well-characterized FCHL 23 (pedigree numbers 2 through 4 were split, resulting in seven families). The probands in pedigree numbers 1 and 2 were survivors of myocardial infarctions. The probands in pedigrees 3 and 4 were markedly hypertriglyceridemic and were thought to possibly represent homozygotes for FCHL, since FCHL was seen in both the maternal and paternal lineages. 47 The current pedigree configurations reflect recent modifications made after incompatibilities were detected with highly polymorphic genetic markers, possibly representing nonpaternities. A single marker inconsistency resulted in pedigree 1 being separated into two nonoverlapping parts for the complex segregation analysis reported here. Seven individuals were excluded from all analyses: 3 were diagnosed with non-insulin-dependent diabetes mellitus, 3 were taking lipid-lowering medications, and 1 had both of these factors. The final family sample contained 216 individuals with apoB levels measured, including 106 men and 110 women. Unadjusted sample means were: triglycerides, 163.0; LDL-C, 121.3 (n=211), and apoB, 114.96 mg/dL. The mean age was 37.5 years. Diagnosis of FCHL was made in pedigree members in whom either triglycerides or LDL-C was greater than the age-and sex-specific 95th percentile or in whom both were above the 90th percentile based on standards established by the Lipid Research Clinics Prevalence Study. 48 
Statistical Analysis
ApoB levels were adjusted for age by using regression results from Jarvik et al 41 for unselected adults. Age and gender adjustment for apoB was computed by adding the sample mean of 114.96 mg/dL to the age on apoB regression residuals for men and for women. Mean adjusted apoB levels for affected and unaffected individuals within each pedigree are shown in Table 1 . Where necessary, for comparison with apoB adjusted only for age and sex, apoB level was further adjusted for LDL subclass phenotypes A, B, and I using separate regressions for each sex.
Complex Segregation Analysis
Complex segregation analysis was used to investigate the transmission of apoB levels. Under the general transmission probability model proposed by Demenais and Elston, 49 the distribution of apoB levels results from the uncorrelated, additive contributions of variability of a single factor with a major effect, polygenes, and an environmental effect specific to the individual. Three conditional distributions, or modes, are associated with the occurrence of a major effect with two factors: Bl, which lowers the individual's apoB level, and Bh, which raises it. The combinations of these factors, B1BI, BIBh, or BhBh, are termed ousiotypes 50 and have apoB distributions with means Mi. Mi. and A4. respectively. The ousiotype effects may be attributable to either a genetic or an environmental factor with a large effect. If the factor is genetic the ousiotypes are identical to genotypes. Deviations from the means within ousiotypes are assumed to be attributable to polygenic plus individual-specific environmental effects that are normally distributed. Of the variance among the individuals with the same ousiotype (cr 1 ) , that fraction which is attributable to polygenic loci is represented by the parameter h 2 . The probabilities that a parent with ousiotype B1B1, BIBh, or BhBh will transmit a Bl factor are T,, T 2 , and T 3 , respectively. 51 The relative frequency of factor Bl isp and that of Bh is q=\-p. The relative frequencies of ousiotypes B1B1, BIBh, and BhBh for individuals whose parents are not sampled are assumed to be p 2 , 2pq, and q 2 , respectively.
Submodels restrict the values of combinations of parameters found in the general model. Under the major environmental model the a priori probability of transmission of the Bl factor is p, regardless of the parental ousiotype: T, = T 2 =T 3 =/?. The mixed codominant model restricts the transmission probabilities T,, T 2 , and T 3 to 1.0, 0.5, and 0.0, respectively, which would be those expected for a single mendelian locus with two alleles. When the mixed codominant model fits as well as the general model but the major environmental model gives a significantly worse fit, it is compared to the mixed dominant model {^=^) and the mixed recessive model (ix x =y^). Mixed models include a porygenic component (h 2 ). Mendelian codominant, dominant, and recessive models have no porygenic component (h 2 =0). To evaluate the possibility of genetic heterogeneity in the transmission of apoB levels among pedigrees, the likelihood for each pedigree was calculated under competing models.
Approximation methods to determine the maximum likelihood estimates and standard errors of the parameter estimates used GEMINI. 32 The model likelihoods on these pedigree data were approximated by the Pedigree Analysis Program (PAP) developed by Hasstedt. 53 ' 54 Hypothesis testing of nested models used the likelihood ratio criterion. The x 1 distribution has degrees of freedom equal to the difference in the number of parameters between the two models being contrasted.
The adjusted apoB levels were not normalized prior to complex segregation analysis because such transformations of a biologically skewed variable can lead to a large reduction in the power to detect a true major gene. 55 The consideration of the major environmental model reduces the possibility that skewness will lead to a false inference of presence of a mendelian locus. 56 No correction for ascertainment was made. The available ascertainment correction strategies would not be adequate to allow appropriate inferences about the population at large 37 because the families were chosen for this analysis based on the presence of FCHL, which is defined by the LDL-C and trigfyceride levels of multiple affected individuals in the pedigree.
Once a model for transmission was established, PAP was used to calculate the probability that each individual had each genotype under that model based on the individual's own phenotype and on the distribution of phenotypes in relatives. If an individual had one particular genotype probability greater than 50% and no other genotype probability greater than 40%, that genotype was assigned. 21 Individuals not meeting these criteria were not assigned genotypes.
Complex segregation analyses were repeated in the 192 of 216 individuals in which LDL subclass phenotypes were measured. However, even before adjustment for LDL subclass phenotype, loss of the 24 individuals without LDL subclass phenotypes resulted in the loss of the ability to fit the general and major environmental models due to boundary problems forp and the transmission probabilities. After adjustment of apoB levels for LDL subclass phenotype as well as age and sex or for the subset of 126 individuals with subclass A, the fit of the mixed mendelian model was contrasted to the major environmental model. Since these models are not nested, the likelihood ratio test is not useful. The Akaike information criterion (A1C), equal to -2 In likelihood plus two times the number of parameters in the model, may be calculated for each model in this case. The model with the lowest AIC is considered the most parsimonious.
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Contingency Analyses
The independence of predicted apoB level genotype and LDL subclass phenotype and that of both from FCHL was tested usinj; either the Pearson x 2 statistic or the MantelHaenszel test for linear association as appropriate for 2x3 tables involving apoB level genotype.
Logistic regression was used to test how apoB level genotype and LDL subclass phenotype aided in the prediction of FCHL for these families. The full model contained phenotype (A, B, and I) and genotype (B1B1, BIBh, and BhBh) marginal effects terms as well as multiplicative phenotype x genotype interaction terms. Phenotype and genotype were coded as dummy variables. Nonsignificant terms were removed from the model in a stepwise fashion. Logistic regression analyses were performed by using the SPSS statistical package revision 5.0, and the contingency analyses used revision 4.1. 39 Caution must be used in the interpretation of these results, as related individuals are included in the analysis. This may bias the results in favor of an association, since related individuals may share the same genotypes at two loci more frequently than the general population. However, related individuals are necessary for the assignment of apoB level genotype, and these four large families do not allow the selection of an unrelated subset of
Results
Complex Segregation Analyses
The results of the complex segregation analysis were consistent with mendelian segregation of a codominant major locus for apoB levels in these pedigrees ( Table 2) . Contrasted to the general model, the major environmental model could be rejected (* The likelihoods for each family under the mixed codominant and the major environmental models (Table 2) were examined for evidence of heterogeneity in the transmission of apoB levels among pedigrees (Table  3) . A lower AIC is found for the mixed mendelian model for all pedigrees except number 3, suggesting a different model for the transmission of apoB levels in this one pedigree. When parameters are estimated using pedigree 3 alone, in order to allow for the presence of a genetic factor with parameters that differ from those found in the entire sample, the mixed mendelian model (-2 In likelihood=629.8) continues to be less likely than the major environmental model (-2 In likelihood=626.4).
The mendelian mixed codominant model was favored over the major environmental model both for age-and sex-adjusted apoB when considering the LDL subclass A phenotype individuals only (n=126), or age-, sex-, and LDL subclass-adjusted apoB (n=192; Table 4 ). These results suggest that the codominant mendelian trait influencing apoB levels is not eliminated by adjustment for subclass phenotype and, in fact, occurs within subclass phenotype A individuals.
Genotype assignments were made under the mixed mendelian model for apoB adjusted for age and sex (Table 2 ). Using the criteria described in "Methods," 146 individuals were assigned genotype B1B1, 34 BIBh, and 7 BhBh. Of those assigned genotypes, the genotype-specific adjusted apoB level means for those affected with FCHL were 109 mg/dL for B1B1, 158 for by guest on February 27, 2013 http://atvb.ahajournals.org/ Downloaded from BlBh, and 205 for BhBh. The means for unaffected individuals were 100 mg/dL for BlBl and 130 for BlBh. Of those assigned genotypes, 69% had a genotype probability of 0.75 or greater. Only 2 of those assigned genotypes had a probability greater than 0.07 for all three genotypes. Of the 29 individuals who could not be assigned a single genotype, the mean probabilities of genotype BlBl, BlBh, and BhBh were 0.47, 0.49, and 0.04, respectively. Two individuals had genotypic probabilities split between the BlBh and BhBh genotypes; the remainder were split between the BlBl and BlBh genotypes.
Independence of LDL Subclass and Putative ApoB Level Genotype
In these families LDL subclass phenotype and apoB level genotype appear to be independent factors, as no association between these traits was apparent ( tPedigree 1 was divided into two parts; see "Methods" for details.
Associations With FCHL
Two-way tables demonstrating the significant associations of apoB level genotype (P<.0001) and LDL subclass phenotype (P<.0001) with FCHL are shown in Table 6 . Table 7 shows these tables within each family. Removing the phenotype I cells from Table 7 results in P values of .7, .06, and .0001 for families 1, 2, and 3, respectively. None of the affected individuals in pedigree 1 carry the Bh allele, which is predictive of FCHL in the other pedigrees (Table 7) .
Pedigree 3 showed a strong association between apoB level genotype and FCHL, but it was the only family for which the complex segregation analysis mixed codominant model did not give a better fit compared with the major environmental model. Because the proband in this family possibly represented a homozygote, 47 the maternal and paternal sides of the pedigree were separated, excluding the proband, the proband's siblings, and their offspring. The mean apoB levels of affected individuals were 120 mg/dL in the paternal and 155 mg/dL in the maternal lineage. All 9 individuals with FCHL and the BlBl genotype (mean adjusted apoB level, 100 mg/dL) were on the paternal side of the pedigree. All Bh alleles came from the maternal side of the pedigree except one, which was from a spouse not biologically related to the proband; thus, the Bh-FCHL association in this family existed only on the maternal side. It is likely that the BlBh proband in this family is a compound heterozygote who has defects in lipid metabolism at two separate loci. The poorer fit to the mixed codominant model may stem from a different etiology for the FCHL, and also the elevated apoB levels, in the paternal side of this pedigree.
Logistic Regression Results
The apoB level genotype-by-LDL subclass phenotype interaction term is significant in the prediction of 
Discussion
Evidence for segregation of a mendelian trait that levels is supported by data from these FCHL families, consistent with the results of previous complex segregation analyses. 16 - 20 Unfortunately, these data are not sufficient to rigorously contrast models for the transmission of LDL subclass phenotype-adjusted apoB levels. However, transmission of a mendelian factor is favored, supporting the hypothesis that the LDL subclass phenotype and apoB level genotype are separate genetic factors. This is consistent with the lack of an association between LDL subclass phenotype and apoB level gen- otype in the contingency analysis as well as the finding of bimodality of apoB levels in individuals with LDL subclass phenotype B. 60 Thus, LDL subclass phenotype and apoB level genotype appear to be separate mendelian traits, both with effects on apoB level and FCHL.
The effects of apoB level genotype and LDL subclass phenotype in the prediction of FCHL suggest a multifactorial threshold model of inheritance of FCHL, in which all BhBh individuals are over the threshold to develop the disorder but in which B1B1 and BIBh individuals may be pushed over the threshold by subclass phenotype B or other factors. If hepatic oversecretion of apoB associated with VLDL is etiologic, 68 then the BhBh genotype may be sufficient to cause FCHL. For the B1B1 and BIBh genotypes the effects of genotype and subclass phenotype in the prediction of FCHL appear additive. Only 47% of the BIBh individuals in the sample were diagnosed with FCHL, and these BIBh individuals had higher apoB levels than unaffected BIBh individuals, perhaps representing those in whom LDL subclass phenotype B or other genetic or environmental factors result in higher apoB levels. An important caveat is that the boundary between those who are and are not considered affected with FCHL is arbitrary, based on a percentiJe cutoff of the continuously distributed LDL-C and triglyceride levels. Thus, it is not unreasonable to expect a threshold model for the etiology of FCHL.
Heterogeneity in the etiology of FCHL has been suggested, 20 -34 - 39 and heterogeneity is also suggested for these families. Variation in LDL subclass phenotype is seen within all the families investigated here; however, pedigree number 1 shows no evidence of an association of the putative Bh allele and FCHL. Similarly, the paternal side of pedigree 3 does not segregate for this Bh allele and has lower apoB levels in affected individuals than are found on the maternal side or in the other families. The proband in this family may have defects at two separate loci; the proband's mother has the BIBh genotype and the proband's father has LPL activity that is one half of normal. 33 Studies evaluating whether LPL deficiency may be associated with FCHL in the paternal side of this family are in progress. Such heterogeneity is consistent with a multifactorial, threshold model for FCHL in which elevation of apoB from a variety of etiologies can contribute to surpassing the threshold for onset of FCHL. FCHL will continue to be a difficult disorder to investigate. The inability to diagnose FCHL in the absence of family data, the potential for overlap in the lipid levels of those who are and are not affected, genetic heterogeneity, and lack of genotypic markers for predictors such as the unmapped loci for apoB level genotype and LDL subclass phenotype are all issues that will continue to confound genetic investigations of FCHL. In particular, these factors present considerable difficulties when one attempts to map a locus for FCHL by using linkage analysis. Wojciechowski et al 38 attempted to account for the heterogeneity by limiting linkage analysis to those families in which the proband had an allele associated with an increase in apoB levels. But others have pointed out that such ascertainment, based on both diagnostic and allele status, introduces a bias of unknown magnitude in favor of the hypothesis of linkage.
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- 39 The use of large pedigrees is expected to increase homogeneity, although with a disorder frequency of 1% to 2% and probable additive genetic influences, the introduction of more than one causative trait may occur in a single large family.
Finally, although the assignment of LDL subclass may be made on the basis of laboratory results, the overlap in apoB distributions does not allow reliable assignment of apoB level genotype without complex segregation analysis, which in turn requires family data. It may be reasonable to separate pedigrees that do and do not have evidence of the apoB level locus allele associated with FCHL to try to define more homogeneous samples for the purpose of linkage analyses. This may only be a first step, as multiple loci with similar effects may not be distinguished from a single locus by using complex segregation analysis. Other markers of heterogeneity within FCHL must be sought. Knowledge of factors that may identify homogeneous subsets of FCHL will aid in the use of linkage analyses to map the genes responsible for this common disorder and to develop intervention strategies to reduce CAD in affected family members.
